Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort ascending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort ascending Functional Area Date Posted
(Senior) Medical Advisor (Radioligand Therapy) Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Research & Development Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Sep 02, 2024
Clinical Development Functional Head London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 03, 2024
Senior Expert, Science & Technology (Analytical Expert) Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
SSO Finance Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Sep 10, 2024
RA Manager, Procedural Documents London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 10, 2024
Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 11, 2024
Senior Regulatory Affairs Manager Vietnam Vietnam Development Innovative Medicines Research & Development Oct 22, 2024
Head, Clinical Development Strategy & Integration Lead Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 12, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Associate Director- Clinical Data Standards Mumbai (Office) India Development Innovative Medicines Research & Development Sep 13, 2024
Senior Global Risk Management Plan Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Sep 16, 2024
Principal Biostatistician Home Worker United Kingdom Development Innovative Medicines Research & Development Sep 17, 2024
Director Quantitative Safety Scientist Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Sep 17, 2024
Global Labelling Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 17, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) China Development Innovative Medicines Research & Development Sep 17, 2024
Expert Science & Technology II- Analytical Research & Development Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Sep 18, 2024
Global Program Clinical Head: In-market Brands London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 18, 2024
Senior Expert, Science & Technology - Potency East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Executive Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Senior Principal Product Operations Manager Hyderabad (Office) India Biomedical Research Innovative Medicines Research & Development Sep 19, 2024
Senior Principal Statistical Programmer - Advanced Quantitative Sciences East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Associate Director, Statistical Programming East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Clinical Development Medical Director - Renal **80-100% Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 20, 2024
Global Program Clinical Head - CRM Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 20, 2024
Associate Director Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 24, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Oct 16, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Oct 17, 2024
Senior Expert Technical Development- Drug Product Project Lead East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Vendor Alliance Lead Associate Director (Remote) East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Global Program Safety Lead - Immunology Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 17, 2024
Strategy Director, Clinical Development Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 17, 2024
Senior Principal Biostatistician Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 03, 2024
Sr Prin Clinical Data Scientist (Data Mgr) East Hanover USA Development Innovative Medicines Research & Development Oct 03, 2024
Senior Regulatory Affairs Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 04, 2024
Senior Principal Biostatistician London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 04, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Oct 06, 2024
Senior Principal Product Operations Manager (EDW-Study management and logistic) Hyderabad (Office) India Biomedical Research Innovative Medicines Research & Development Sep 25, 2024
Medical Scientific Liaison İstanbul Kavacık Turkey International Innovative Medicines Research & Development Sep 26, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Sep 26, 2024
Clinical Development Medical Director - Cardio-Renal-Metabolism East Hanover USA Development Innovative Medicines Research & Development Sep 26, 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development Sep 27, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
Clinical Development Medical Director Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 30, 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia